Using RapidFire technology, organizations have gained new insights into drug targets that they never would have attempted in the past — either because it would be too costly, time consuming, or difficult to obtain reliable data.
Below is just a sampling of the applications for which RapidFire technology has been used either by or for our collaborators. Many of these studies are published in scientific journals.
- Protein kinases (ATK1/PKBa, Lck Kinase)
- Protein hydroxylases (FIH)
|
- Phosphatidylserine decarboxylase
|
| INFLAMMATION / PAIN |
ANTI-INFECTIVES |
- Fatty acid amide hydrolase
- Lipoxygenases (5-LOX, 15-LOX)
|
- UDP-3-O(R-3-hydroxymyristoyl)-deacetylase [LpxC]
|
| CARDIOVASCULAR DISEASE |
NEUROLOGY |
- Phosphatidylethanolamine N-methyltransferase
- Phospholipase A2
- Cystathioninesynthase
|
- Phytanoyl-CoA hydroxylase
- Acetylcholinesterase
|
| EPIGENETICS |
METABOLIC DISORDER / DIABETES |
|